Skip to main content
Pioglitazone tied to better health outcomes in stroke, prediabetes

Canadian researchers found that stroke patients with prediabetes who received pioglitazone had a 40% reduction in the composite outcome of myocardial infarction and stroke, and a 33% reduction in stroke alone over 4.8 years, compared with those on placebo, according to a study published in JAMA Neurology and presented at the International Stroke Conference. Based on 3,876 patients, findings revealed that patients with good adherence also had an 80% reduction in new-onset diabetes.

Full Story: